The platform is aimed at improving adherence to treatment regimens through reminders to take medications, refill prescriptions, and visit healthcare providers. It works with almost any phone with web browsing capabilities, regardless of platform or service provider, including iPhone(r), BlackBerry(r) and Android(tm) devices and many feature phones.
The mobile adherence platform can be utilised for prescription or over-the-counter medication or nutritional supplement, including, but not limited to, products from the Johnson & Johnson Family of Companies.
Perrigo to acquire United States rights for Entocort from AstraZeneca
US FDA approves Boehringer Ingelheim's Pradaxa
Phase II clinical trial for potential treatment of androgenetic alopecia completed by Samumed
Life Sciences Partners collaborates on immuno-oncology with Bristol-Myers Squibb
Arsanis initiates first cohort in Phase one clinical trial of ASN100
Impax introduces generic Avodart (Dutasteride) Capsules, 0.5 mg
Mylan unveils generic FazaClo orally disintegrating tablets for treating schizophrenia